MedTrace Logo

Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO

NCT04405973 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2020-11-04

No results posted yet for this study

Summary

The prognosis of patients with severe COVID-19 disease, whose lungs are so severely diseased that they need to be supported by veno-venous ECMO (extracorporeal membrane oxygenation), is difficult to assess so far. Previously published data from studies, case reports and case series describe a very high mortality in this patient collective. The significance of established clinical prognostic cores in this patient population has not been systematically investigated. This is aggravated by the fact that even at very specialized centers only very few patients from this collective are (can be) treated, so that valid investigations are only possible in a multicenter patient collective. In this registry study, all patients diagnosed with COVID-19 and treated with vv-ECMO in the centers participating in the study should be retrospectively examined. The primary aim of the study is to investigate 30-day survival, secondary objectives include the analysis of different clinical scores at the time of ECMO implantation.

Conditions

  • COVID-19
  • SARS-CoV 2
  • Extracorporeal Membrane Oxygenation
  • ARDS

Interventions

DEVICE

vv-ECMO

vv-ECMO required in severe COVID-19 ARDS

Sponsors & Collaborators

  • Dr. Alexander Supady

    lead OTHER

Principal Investigators

  • Alexander Supady, MD, MPH · University Clinic Freiburg

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-19
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405973 on ClinicalTrials.gov